----item----
version: 1
id: {408CB29E-9D4C-4F88-B235-09292B9BC0BB}
database: master
path: /sitecore/content/Pharma/MedtechInsight/Home/Articles/1995/07/10/E Merck reports 13 sales rise for biomaterials
parent: {98BAB990-6283-4E08-9540-D71A757446F0}
name: E Merck reports 13 sales rise for biomaterials
master: {00000000-0000-0000-0000-000000000000}
template: {11380B5D-3531-4570-B213-EFC5312266E4}
templatekey: Article

----field----
field: {A4F985D9-98B3-4B52-AAAF-4344F6E747C6}
name: __Workflow
key: __workflow
content-length: 38

{926E6200-EB76-4AD4-8614-691D002573AC}
----version----
language: en
version: 1
revision: 697972de-a8e5-44d7-b804-6ccc40fba3ec

----field----
field: {5BA0578F-65B7-4C22-8233-1603D698D8A4}
name: Summary
key: summary
content-length: 266

<p>E Merck, the German pharmaceutical, laboratory equipment and chemicals group, has highlighted the strong performance of its biomaterials business last year. The division had sales of DM 91 million ($65 million) in 1994, up 13% compared with the previous year.</p>
----field----
field: {2D750EFF-9058-4ABF-A7FF-57FFE5DA1E3C}
name: Title
key: title
content-length: 47

E Merck reports 13% sales rise for biomaterials
----field----
field: {446A339B-E1D9-4DE1-8B5E-DB7942EF1723}
name: Body
key: body
content-length: 1179

<p>E Merck, the German pharmaceutical, laboratory equipment and chemicals group, has highlighted the strong performance of its biomaterials business last year. The division had sales of DM 91 million ($65 million) in 1994, up 13% compared with the previous year.</p><p>Merck Biomaterial is based on a French-German axis which includes E Merck's German subsidiary, Artos (Berlin), and two French subsidiaries, Impact (Valence) and Prothaid (Paris). The latter was acquired earlier this year. The biomaterials business manufactures bone cements and application sets, antibiotic delivery systems and bone replacement materials.</p><p>E Merck estimates the European orthopaedics market at DM 1,500 million ($1,000 million) of which DM 700 million is generated in Germany and France. Merck Biomaterial is part of E Merck's pharmaceutical business which had sales of DM 2,970 million last year. Total group sales were DM 5,660 million.</p><p>E Merck introduced Trios, its hip joint replacement system, in Germany at the end of last year. In the pipeline at Merck Biomaterial is a special bone cement for fracture treatment intended to eliminate the use of osteosynthesis materials.</p>
----field----
field: {0212FC0F-953B-461C-B4D9-B7483A4D4F1B}
name: Taxonomy
key: taxonomy
content-length: 116

{F5161CC2-772F-472E-A21C-BF196343462E}|{FC1DA89F-D8A0-415D-99B6-86FF397EC709}|{2EDCC1FF-26E4-4C6E-AF73-0F43F0F033B8}
----field----
field: {8F4EE718-6FA0-42A5-85C4-6C8FE8B1FCD4}
name: Navigation Title
key: navigation title
content-length: 46

E Merck reports 13 sales rise for biomaterials
----field----
field: {7C4FC796-1311-4DAA-81AC-85EAA2C1C108}
name: Actual Publish Date
key: actual publish date
content-length: 15

19950710T000000
----field----
field: {BDF7C8E1-869E-49FF-B9F5-854B3081A45D}
name: Created Date
key: created date
content-length: 15

19950710T000000
----field----
field: {C926A72A-39DA-446D-B78C-2A650F820A73}
name: Modified Date
key: modified date
content-length: 15

19950710T000000
----field----
field: {1616FE67-7278-4169-948E-C29B00EC8781}
name: Article Number
key: article number
content-length: 8

MT053390
----field----
field: {2C985172-2B37-4CFE-AEDE-2A42EC833941}
name: Content Type
key: content type
content-length: 38

{832554E5-EC9E-4747-8623-6770D36CAF32}
----field----
field: {31603F25-6D9C-4954-BCDE-342E1E184A30}
name: Meta Title Override
key: meta title override
content-length: 47

E Merck reports 13% sales rise for biomaterials
----field----
field: {AE1BD751-D4E7-49CB-96C4-62E995A06B51}
name: Article Category
key: article category
content-length: 4

News
----field----
field: {0F6C8F42-01DC-4E05-B63E-AA25D8AA0E09}
name: Legacy Publication
key: legacy publication
content-length: 38

{FF38DC83-07D4-43F0-8C55-84EB64FAF35A}
----field----
field: {5795FF15-0942-41FF-8A77-3B73185F5E1B}
name: Escenic ID
key: escenic id
content-length: 6

255199
----field----
field: {25BED78C-4957-4165-998A-CA1B52F67497}
name: __Created
key: __created
content-length: 16

20160622T184501Z
----field----
field: {5DD74568-4D4B-44C1-B513-0AF5F4CDA34F}
name: __Created by
key: __created by
content-length: 18

sitecore\Anonymous
----field----
field: {8CDC337E-A112-42FB-BBB4-4143751E123F}
name: __Revision
key: __revision
content-length: 36

697972de-a8e5-44d7-b804-6ccc40fba3ec
----field----
field: {D9CF14B1-FA16-4BA6-9288-E8A174D4D522}
name: __Updated
key: __updated
content-length: 16

20160622T184501Z
----field----
field: {BADD9CF9-53E0-4D0C-BCC0-2D784C282F6A}
name: __Updated by
key: __updated by
content-length: 18

sitecore\Anonymous
----field----
field: {3E431DE1-525E-47A3-B6B0-1CCBEC3A8C98}
name: __Workflow state
key: __workflow state
content-length: 38

{962542F5-554E-4DE8-BE4C-B0796FDAC854}
